SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors digest significant institutional accumulation and strategic partnerships, including a recent major defense contract and collaboration with top-tier technology firms. Community sentiment remains bullish, with many traders focusing on the company's long-term potential as an AI infrastructure leader and anticipating a breakout from its recent trading range.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing a surge in investor interest driven by recent production order wins for its Sonoma high-power test platforms, which are being integrated into critical hyperscale AI infrastructure. The community is focused on the potential for a massive commercial scale-up in the coming year, with active debates centered on whether recent contract wins represent a definitive pivot toward sustainable, high-volume growth that justifies current valuation levels.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing intense community focus as traders brace for potential market volatility stemming from escalating tensions in the Middle East and concerns over oil supply disruptions. Investors are actively debating whether recent diplomatic overtures are genuine or merely market-calming maneuvers, leading to significant volume in both hedging and speculative positions around the ETF.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

The MATH community is actively debating the token's potential for a significant breakout, fueled by its low market cap and historical patterns of sudden, sharp volatility. While some investors are expressing frustration over stagnant price action and questioning leadership, others remain optimistic that upcoming altcoin cycle trends could act as a catalyst for a sustained move upward.

ElizaOS

ELIZAOS is capturing significant trader interest as the community focuses on a major token migration and the potential for a technical rebound following recent volatility. Investors are actively debating key support levels and monitoring for a breakout, driven by the project's expanding role in cross-chain AI agent infrastructure and ongoing exchange-led promotional campaigns.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USD Coin is gaining attention as community members analyze its structural growth, regulatory developments, and expanding utility across major blockchain networks. Sentiment is mixed, with some focusing on long-term institutional adoption and stablecoin integration into decentralized finance, while others express concerns regarding centralization risks and broader regulatory uncertainty.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is attracting intense retail attention as traders debate the ETF's structural decay and its role as a high-volatility hedge against Middle East geopolitical instability. The community remains sharply divided between those betting on aggressive upside driven by fear-based volume and those advocating for short positions to capitalize on the instrument's long-term negative roll yield.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is attracting heavy investor attention ahead of their upcoming earnings release, with community discussion centered on whether the company can deliver a decisive revenue beat to counter ongoing skepticism. Shareholders are closely watching for potential regulatory catalysts and management's strategy, while a vocal contingent of traders remains divided between those betting on a long-term turnaround and those bracing for further volatility and dilution.

USELESS

USELESS is gaining significant community traction as traders track its consolidation phase and potential for a breakout amid broader altcoin rotation. Discussion centers on its high-beta profile and the irony of its branding, with active debates split between bullish accumulation strategies and skeptical views on its meme-driven longevity.

Boyd Gaming Corp. is a multi-jurisdictional gaming company, which engages in the management and operation of gaming and entertainment properties. It operates through the following segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Las Vegas Locals segment consists of eight casinos that primarily serve the resident population in the Las Vegas metropolitan area. The Downtown Las Vegas segment refers to the following casinos: California Hotel and Casino, Fremont Hotel and Casino, and Main Street Station Hotel and Casino. The Midwest and South segment includes four land-based casinos, six dockside riverboat casinos, three racinos, and four barge-based casinos that operate in nine states in the Midwest and southern United States. The Online segment includes the operating results of online gaming operations. The company was founded by William Samuel Boyd and Sam Boyd on January 1, 1975 and is headquartered in Las Vegas, NV.

Boyd Gaming Corp.

Boyd Gaming is trending as traders speculate on potential M&A activity following reports that the company has approached Penn Entertainment regarding a possible acquisition, while community members actively debate the differences between this regional casino operator and the Chinese EV manufacturer. Investors are closely monitoring these consolidation rumors, particularly the potential for a split of brick-and-mortar assets and digital gaming divisions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

India-EU trade deal: OneSource Specialty, Syngene, Sigachi, other pharma stocks tank up to 19%; here's why

… lower input costs for Indian pharma companies sourcing specialised ingredients from … stocks. On BSE, OneSource Specialty Pharma (19%), Syngene International (11%), Sigachi … .41%), Wanbury Ltd (7%), Kwality Pharmaceuticals (5.67%), Supriya Lifescience (6% …

GSK Pharma to Procure 4.95 MWp Solar Power from CleanMax in Maharashtra

GlaxoSmithKline Pharmaceuticals (GSK Pharma ) will procure 4.95 MWp … , Syngene International, a Bengaluru-based pharmaceutical company, announced procuring renewable energy … February 2025, Mumbai-based Aarti Drugs partnered with Prozeal Green Energy …

Healthcare stocks in India fell on Friday as investors weighed the impact of U.S. President Donald Trump’s move to impose a 100% tariff on branded and patented drugs starting Oct. 1.&nbsp;The measure, announced in late-night Truth Social posts, exempts only those manufacturers with U.S. plants that are already under construction or have broken ground.The Nifty Healthcare index fell 1.2% on Thursday, with 18 of its 20 components trading lower.&nbsp;IPCA Laboratories remained unchanged, while Torrent Pharma rose 0.01%.Analyst ViewSEBI-registered analyst&nbsp;<a href="https://stocktwits.com/ra_vishaltrehan">Vishal Trehan</a> said Gland Pharma is the most exposed, given its lack of a U.S. manufacturing footprint and reliance on branded or patented formulations.&nbsp;<stembedurl>https://stocktwits.com/ra_vishaltrehan/message/630078378</stembedurl>He noted that Syngene International, Piramal Pharma, and Zydus Lifesciences stand to benefit from their contract manufacturing models and biologics portfolios, which are less tariff-sensitive.Trehan also pointed out that companies with a large branded generics or biosimilars presence, such as Dr. Reddy’s Laboratories and Biocon, will need to accelerate U.S. production to avoid margin erosion.Trump’s Pharma TariffsThe announcement builds on Trump’s escalating trade measures aimed at repatriating drug manufacturing. Last month, he outlined a phased plan, beginning with a “small tariff” on imported drugs, before lifting duties to 150% within 18 months and ultimately to 250%.&nbsp;Pharmaceuticals had earlier been excluded from his reciprocal tariff program, but the new rules extend to prescription medicines, biologics, specialty drugs, and over-the-counter products, with generic drugs remaining exempt.What Is The Retail Mood?On Stocktwits, retail sentiment for Piramal Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories was ‘bearish’ amid ‘normal’ message volume.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/GLAND.NSE">Gland Pharma</a> has risen 6.5%, while&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene International</a> is down 29.1%,&nbsp;<a href="https://stocktwits.com/symbol/PPLPHARMA.NSE">Piramal Pharma</a> has slipped 25.9%,&nbsp;<a href="https://stocktwits.com/symbol/ZYDUSLIFE.NSE">Zydus Lifesciences</a> is up 1.8%,&nbsp;<a href="https://stocktwits.com/symbol/DRREDDY.NSE">Dr. Reddy’s Laboratories</a> is down 7.2%, and&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a> has fallen 6.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s

The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.

Equity

Indian equity markets ended higher on Wednesday, supported by strong buying in IT and FMCG stocks. This marked a fifth successive session of gains with the Nifty index ending above 25,000 for the first time since July.The markets are likely to open flat-to-slightly positive on Thursday, tracking broader Asian markets. Investors will be keeping a close watch on the developments around trade talks between India and Russia, as well as the upcoming Shanghai Cooperation Organisation (SCO) summit.The Gift Nifty, an early indicator for the Nifty 50 index, was up 0.11% to 25,113.5 at 8:35 am IST.Here are the stocks to watch out for heading into today’s session.Stocks To WatchVedanta: Board meeting today to mull second interim dividend for this financial year.Clean Science and Technology: Promoters Ashok Boob and Krishna Boob plan to sell up to 24% stake via block deals worth ₹2,626 crore, with a floor price of ₹1,030 per share, as per reports.India Cements: UltraTech Cement will offload a 6.49% stake (2.01 crore shares) through an OFS on August 21–22, with a floor price set at ₹368 per share.RailTel Corporation of India: Bags orders worth ₹50.4 crore, including ₹35 crore from Kerala IT Mission for the SDC project and ₹15.4 crore from Odisha’s Higher Education Department.Jupiter Wagons: Subsidiary Jupiter Tatravagonka Railwheel Factory received an LOI to supply 5,376 wheelsets for Vande Bharat Trains, valued at ₹215 crore.Zee Entertainment: Aditya Birla Finance challenges an arbitral award in the Delhi High Court. The dispute pertains to a ₹134-crore term loan to Siti Networks, linked to a letter of comfort allegedly issued by Zee.Exide Industries: Invests ₹100 crore in its subsidiary Exide Energy Solutions via rights issue, taking its total investment to ₹3,802.23 crore without altering its shareholding.Godrej Properties: Acquires a 7% stake in Godrej Skyline Developers from an existing shareholder.Syngene International: Appoints five senior leaders across strategy, technology, research, chemistry, and biology, all joining its Executive Committee.Sula Vineyard: Reportedly exploring entry into premium spirits and is in talks with smaller brands for potential acquisitions to foray into whisky, scotch, and vodka markets.Fortis Healthcare: Signs an agreement with Ekana Group to manage a 550-bed super specialty hospital in Lucknow’s Gomti Nagar.Hitachi Energy India: Board appoints Ismo Antero Haka as Chairman and Jan Niklas Persson as Additional Director, while Achim Michael Braun stepped down.Innova Captab: Clears UK-MHRA inspection for its Cephalosporin plant in Baddi with no major or critical observations.Nucleus Software Exports: Vishnu R Dusad named Interim CFO effective August 20, while continuing as Managing Director.SMC Global Securities: To invest ₹15 crore in equity shares of NCDEX.Popular Vehicles and Services: Subsidiary Prabal Motors acquires BharatBenz dealership operations in Punjab from Globe CV.Paradeep Parivahan: Acquires 100% stake in four entities: Pharmachem Traders, Nirkon Industries, MRTC (India), and ASK Logistiek Solutio.Crisil: Subsidiary Crisil Irevna UK approves setting up a wholly owned arm, Crisil Canada Inc.Thermax: Acquires the remaining 23.03% stake in Thermax Bioenergy Solutions, making it a wholly owned subsidiary.Fedbank Financial Services: Board to meet on August 25 to consider issuing NCDs worth up to ₹2,500 crore.Signpost India: Partners with EY LLP for a three-year transformation program focused on governance, digital infrastructure, and scalability.CAMS: RBI clears transfer of CAMS’ payment aggregator business to its subsidiary CAMSPAY, after which CAMS will surrender its license.Enviro Infra Engineers: PTC India Financial Services signed agreements with subsidiary EIE Renewables for management transfer of Vento Power Infra under a ₹115.6 crore debt resolution plan.Poly Medicure: NCLT Allahabad has approved the company’s resolution plan for Himalayan Mineral Waters under IBC.Super Iron Foundry: Subsidiary SIF Saudi Arabia signs a 10-year land lease with Saudi Industrial Authority to set up a new foundry unit.Prostarm Info Systems: Emerges as L-1 bidder for a 150 MW / 300 MWh battery energy storage system at Gadag, Karnataka, for KPTCL.RACL Geartech: Secures long-term order to supply transmission gears for premium motorcycles from a leading Indian manufacturer.Earnings ImpactShanti Gold International:&nbsp;Q1 Profit zooms 174% to ₹24.6 crore, while revenue increases 22.1% to ₹292.8 croreActive IPOsGem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, Mangal Electrical IndustriesFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Trading Radar For August 21: Vedanta, Zee Entertainment, Clean Science, India Cements, Railtel Are On Stocks Watchlist

Gem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, and Mangal Electrical Industries IPOs are currently open for subscription

Syngene International reports 11% revenue growth and 59% net profit surge in Q1

Syngene International, a Biocon subsidiary, reveals an 11% revenue increase to Rs 875 crore for the first quarter. Net profit jumps 59% to Rs 87 crore. Growth is attributed to research services and biologics manufacturing. Operations commenced at Unit III in Bengaluru. Preparations advance for the Bayview facility in the US.

Ahead of reporting its quarterly results on Wednesday, Syngene International, a pharmaceutical sector services provider, appears to be locked in a range-bound trade.The stock is currently positioned just above a key support zone between ₹645 and ₹669, as observed by SEBI-registered <a href="https://stocktwits.com/billiondreamz">analyst Rohit Mehta</a>. A recent bounce from this level, accompanied by rising volume, suggests the emergence of short-term bullish momentum.<stembedurl>https://stocktwits.com/billiondreamz/message/621887004</stembedurl>While the broader trend remains corrective since its December 2024 peak, the current consolidation near support could signal the early stages of a base formation. A sustained move above ₹700 would confirm strength, while ₹960 remains a key resistance on the upside, Mehta said.Currently trading at ₹683, <a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene International shares</a> are down 29% from its all-time high of ₹960.20.From an operating standpoint, the company reported healthy results in the March 2025 quarter. Revenue rose 11.01%, while operating profit grew 8.52%, although EPS slipped 3%. Despite solid operating metrics, valuation remains on the higher side at 5.78 times book value, with a modest 12.3% ROE and a low dividend payout of 10.3%.Promoter holding dipped slightly to 52.68% in June 2025, while foreign institutional investors (FIIs) reduced their stake from 19.47% to 16.51%. Domestic institutional investors (DIIs), however, increased their holding to 24.05%.Syngene has witnessed a heavy selling pressure this year, with the stock losing over a fifth of its value YTD.However, it currently appears to be stabilizing near a strong support zone with investors cautiously awaiting the results, hopeful of a trend reversal.For updates and corrections, email newsroom[at]stocktwits[dot]com

A man browses a stock market app during the union budget announcement by Nirmala Sitharaman at the Bombay Stock Exchange headquarters in Mumbai, India, on February 1, 2025. (Photo by Indranil Aditya/NurPhoto via Getty Images)

Syngene Consolidates Ahead Of Q1 Earnings: SEBI RA Rohit Mehta Sees Potential Breakout Above ₹700

Ahead of reporting its quarterly results on Wednesday, Syngene International, a pharmaceutical sector services provider, appears to be locked in a range-bound trade.

While past earnings have been positive, the stock trades at a high valuation and offers a low dividend payout

India’s renewable energy, pharmaceutical, and infrastructure sectors are gaining investor attention heading into July, driven by structural growth drivers such as government incentives, global demand, and a stable policy environment.SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/billiondreamz">Rohit Mehta</a> said smart money is rotating into these three sectors, driven by long-term fundamentals.&nbsp;<stembedurl>https://stocktwits.com/billiondreamz/message/619543180</stembedurl>In renewable energy, Mehta cited India’s ₹24,000 crore PLI scheme for solar modules, rising domestic installations toward the 175+ GW 2030 target, and global deals like Waaree Solar Americas’ 540 MW order.&nbsp;He flagged&nbsp;<a href="https://stocktwits.com/symbol/WAAREEENER.NSE">Waaree Energies</a>,&nbsp;<a href="https://stocktwits.com/symbol/INOXWIND.NSE">Inox Wind</a>,&nbsp;<a href="https://stocktwits.com/symbol/SERVOTECH.NSE">Servotech Power</a>, and&nbsp;<a href="https://stocktwits.com/symbol/KPIGREEN.NSE">KPI Green Energy</a> as key stocks to watch.In pharma, Mehta noted a shift from low-margin generics to high-value contract research and manufacturing services (CRAMS), contract development and manufacturing organizations (CDMO), and biosimilars, driven by the China+1 strategy and increased production-linked incentive (PLI) support.&nbsp;<a href="https://stocktwits.com/symbol/SUVEN.NSE">Suven Pharma</a>,&nbsp;<a href="https://stocktwits.com/symbol/DIVISLAB.NSE">Divi’s Labs</a>,&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a>,&nbsp;<a href="https://stocktwits.com/symbol/NEULANDLAB.NSE">Neuland Labs</a>, and&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene</a> were highlighted for their strong positioning.On infrastructure, Mehta pointed to ₹11 lakh crore in capital expenditure plans in the FY26 Budget and continued momentum in railways, metros, defense, and electrification.&nbsp;He named&nbsp;<a href="https://stocktwits.com/symbol/LTTS.NSE">L&amp;T</a>,&nbsp;<a href="https://stocktwits.com/symbol/IRB.NSE">IRB Infra</a>,&nbsp;<a href="https://stocktwits.com/symbol/KEC.NSE">KEC International</a>,&nbsp;<a href="https://stocktwits.com/symbol/KNRCON.NSE">KNR Construction</a>,&nbsp;<a href="https://stocktwits.com/symbol/AHLUCONT.NSE">Ahluwalia Contracts</a>,&nbsp;<a href="https://stocktwits.com/symbol/POLYCAB.NSE">Polycab</a>, and&nbsp;<a href="https://stocktwits.com/symbol/KEI.NSE">KEI Industries</a> as top beneficiaries.For updates and corrections, email newsroom[at]stocktwits[dot]com.

July Stock Themes: SEBI RA Rohit Mehta Flags Renewables, Pharma, Infra Sectors For Big Rotations

India's clean energy push, pharma transformation, and record capex plans are drawing investor focus heading into July, with key beneficiaries emerging across all three sectors. 

Syngene International Ltd. engages in the contract research and manufacturing services to pharmaceutical and biotechnology companies. Its services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	2.12	--	--	N/A
Q3 '25	2.46	--	--	N/A
Q2 '25	2.17	1.80	-16.92%	MISSED
Q1 '25	1.59	--	--	N/A
Q4 '24	4.44	--	--	N/A

SYNGENE.NSE
Syngene International Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SYNGENE.NSE News

SYNGENE.NSESyngene International Ltd.